3.60
6.19%
0.21
Handel nachbörslich:
3.55
-0.05
-1.39%
Schlusskurs vom Vortag:
$3.39
Offen:
$3.45
24-Stunden-Volumen:
4.61M
Relative Volume:
7.24
Marktkapitalisierung:
$165.70M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-147.71M
KGV:
-1.004
EPS:
-3.5857
Netto-Cashflow:
$-127.89M
1W Leistung:
-73.25%
1M Leistung:
-75.03%
6M Leistung:
-78.86%
1J Leistung:
-83.64%
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Firmenname
Cargo Therapeutics Inc
Sektor
Branche
Telefon
650-499-8950
Adresse
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Vergleichen Sie CRGX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
3.60 | 165.70M | 0 | -147.71M | -127.89M | -3.5857 |
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-11-26 | Eingeleitet | William Blair | Outperform |
2024-07-22 | Eingeleitet | H.C. Wainwright | Buy |
2024-07-08 | Eingeleitet | Chardan Capital Markets | Buy |
2024-06-27 | Eingeleitet | Piper Sandler | Overweight |
2023-12-05 | Eingeleitet | JP Morgan | Overweight |
2023-12-05 | Eingeleitet | Jefferies | Buy |
2023-12-05 | Eingeleitet | TD Cowen | Outperform |
2023-12-05 | Eingeleitet | Truist | Buy |
Alle ansehen
Cargo Therapeutics Inc Aktie (CRGX) Neueste Nachrichten
Stock summary: CARGO Therapeutics reflected weekly fall of 73.11% - Business Upturn
CARGO Therapeutics (NASDAQ:CRGX) Reaches New 12-Month LowShould You Sell? - MarketBeat
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Underweight at JPMorgan Chase & Co. - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by Chardan Capital - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Rating Lowered to Hold at Jefferies Financial Group - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Lowered by William Blair - Defense World
CARGO Therapeutics stock hits 52-week low at $3.12 - MSN
JPMorgan Chase & Co. Acquires 6,426 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Cut to Hold at Truist Financial - MarketBeat
Where are the Opportunities in (CRGX) - Stock Traders Daily
HC Wainwright & Co. Downgrades CARGO Therapeutics (CRGX) - MSN
Truist Securities Downgrades CARGO Therapeutics (CRGX) - MSN
Chardan cuts Cargo Therapeutics stock rating to neutral - MSN
Market Shocks: Crown Electrokinetics, China Liberal Education, and CARGO Therapeutics Plummet, While Foxx Development and Alpha Modus Skyrocket – Market - HPBL
Stock Market Movers: FOXX and AMOD Surge While CRGX and CRKN Face Sharp Declines - HPBL
Bay Area biotech firm guts staff, shuts trial after dangerous side effects - SFGATE
Chardan Capital Downgrades CARGO Therapeutics (CRGX) - MSN
CRGX Investors Have Opportunity to Join CARGO Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm - The Malaysian Reserve
CARGO Therapeutics, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsCRGX - PR Newswire
JPMorgan cuts Cargo Therapeutics stock rating to Underweight - MSN
CARGO Therapeutics stock hits 52-week low at $3.12 By Investing.com - Investing.com Australia
Stock market news: Crown Electrokinetics -99.50%, CARGO Therapeutics -74.34% among biggest losers during mid day trading - Business Upturn
JPMorgan cuts Cargo Therapeutics stock rating to Underweight By Investing.com - Investing.com Canada
Peninsula biotech moves from IPO to chopping half its workforce in little more than a year - The Business Journals
Piper Sandler cuts Cargo Therapeutics rating to neutral By Investing.com - Investing.com Australia
Stock market today: Aclarion -99.69%, CARGO Therapeutics -76.31% among biggest losers in early trading - Business Upturn
Dow Jumps Over 100 Points; Tesla Earnings Miss Views - Benzinga
Cargo to drop lead CAR-T therapy, lay off staff after study setback - BioPharma Dive
Truist cuts Cargo Therapeutics rating, slashes PT to $7 By Investing.com - Investing.com Australia
This Everest Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga India
Truist cuts Cargo Therapeutics rating, slashes PT to $7 - Investing.com India
Jefferies Downgrades CARGO Therapeutics to Hold From Buy, Price Target is $3 -January 30, 2025 at 07:31 am EST - Marketscreener.com
HC Wainwright Downgrades CARGO Therapeutics to Neutral From Buy -January 30, 2025 at 07:19 am EST - Marketscreener.com
Cargo Therapeutics stock tumbles after trial setback By Investing.com - Investing.com Canada
Cargo Therapeutics stock tumbles after trial setback - Investing.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Chardan Downgrades CARGO Therapeutics to Neutral From Buy, Withdraws $28 Price Target - Marketscreener.com
Chardan cuts Cargo Therapeutics stock rating to neutral By Investing.com - Investing.com South Africa
Cargo Therapeutics stock rating cut by Jefferies to Hold - Investing.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating CARGO Therapeutics, Inc. (CRGX) And Encourages Stockholders to Connect - Markets Insider
Piper Sandler cuts Cargo Therapeutics rating to neutral - MSN
CARGO Therapeutics, Inc. Announces Workforce Reduction and Strategic Shift - Defense World
CARGO halts Phase 2 study of cancer treatment - Investing.com India
CARGO halts Phase 2 study of cancer treatment By Investing.com - Investing.com Australia
Stocks to Watch : Tesla, IBM, Microsoft, Lam Research, Cargo Therapeutics -January 29, 2025 at 07:16 pm EST - Marketscreener.com
Stocks to Watch: Tesla, IBM, Microsoft, Lam Research, Cargo Therapeutics - MarketWatch
Cargo Therapeutics to Lay Off 50% of Workers, Stop Developing Blood Cancer Treatment - MarketWatch
CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of - GlobeNewswire
Major Setback: CARGO's Cancer Treatment Shows Alarming Safety Issues, Forces Company Restructure - StockTitan
Fennec Pharmaceuticals (NASDAQ:FENC) versus CARGO Therapeutics (NASDAQ:CRGX) Financial Survey - Defense World
CARGO Therapeutics (NASDAQ:CRGX) Stock Price Up 6.7%What's Next? - MarketBeat
Finanzdaten der Cargo Therapeutics Inc-Aktie (CRGX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):